<DOC>
	<DOCNO>NCT02300961</DOCNO>
	<brief_summary>This pilot study primarily evaluate feasibility adherence iPad-based neurocognitive intervention program . It secondarily evaluate performance neurocognitive test post-transplant change performance subsequent year .</brief_summary>
	<brief_title>Feasibility Neurocognitive Outcome After Transplant</brief_title>
	<detailed_description />
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>All patient must histologic cytological diagnosis ALL treat stem cell transplantation . There restriction prior therapy . Patients must age 6 year 21 year age ( inclusive ) , discrimination base gender , race , creed , ethnic background . The age limit set 6 year age order ensure patient able participate specific cognitive rehabilitation task . ECOG/KPS employ . Patient and/or parents/guardians appropriate must sign informed consent , mentally responsible , able understand willing sign write informed consent . Subjects significant concurrent medical complication judgment Principal Investigator ( ) could affect patient 's ability complete plan trial . There therapy restriction restriction regard use Investigational Agents . Pregnant patient exclude .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>